- Filed
- May 8, 2014 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2014 · May 2, 2014 | 107.99M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2014 | 106.54M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2014 | 103.74M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2013 | 96.81M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2013 | 95.62M sh |
| Capex | Q3 2014 · Mar 31, 2014 | $8.73M |
| Capex | Q3 2014 · Mar 31, 2013 | $10.9M |
| Cash And Equivalents | Q3 2014 · Mar 31, 2014 | $225.15M |
| Cash And Equivalents | Q3 2014 · Jun 30, 2013 | $238.35M |
| Cash And Equivalents | Q3 2014 · Mar 31, 2013 | $354.65M |
| Cash And Equivalents | Q3 2014 · Jun 30, 2012 | $321.24M |
| Stockholders Equity | Q3 2014 · Mar 31, 2014 | $459.39M |
| Stockholders Equity | Q3 2014 · Jun 30, 2013 | $490.42M |
| Current Liabilities | Q3 2014 · Mar 31, 2014 | $94.37M |
| Current Liabilities | Q3 2014 · Jun 30, 2013 | $83.44M |
| Current Assets | Q3 2014 · Mar 31, 2014 | $383.36M |
| Current Assets | Q3 2014 · Jun 30, 2013 | $388.15M |
| Total Assets | Q3 2014 · Mar 31, 2014 | $587.35M |
| Total Assets | Q3 2014 · Jun 30, 2013 | $607.45M |
| Eps Diluted | Q3 2014 · Mar 31, 2014 | −$0.29 |
| Eps Diluted | Q3 2014 · Mar 31, 2014 | −$0.77 |
| Eps Diluted | Q3 2014 · Mar 31, 2013 | −$0.21 |
| Eps Diluted | Q3 2014 · Mar 31, 2013 | −$0.15 |
| Eps Basic | Q3 2014 · Mar 31, 2014 | −$0.29 |
| Eps Basic | Q3 2014 · Mar 31, 2014 | −$0.77 |
| Eps Basic | Q3 2014 · Mar 31, 2013 | −$0.21 |
| Eps Basic | Q3 2014 · Mar 31, 2013 | −$0.15 |
| Sga Expense | Q3 2014 · Mar 31, 2014 | $11.62M |
| Sga Expense | Q3 2014 · Mar 31, 2014 | $36.66M |
| Sga Expense restated | Q3 2014 · Mar 31, 2013 | $16.98M |
| Sga Expense restated | Q3 2014 · Mar 31, 2013 | $45.12M |
| Rd Expense | Q3 2014 · Mar 31, 2014 | $30.55M |
| Rd Expense | Q3 2014 · Mar 31, 2014 | $86.75M |
| Rd Expense restated | Q3 2014 · Mar 31, 2013 | $26.04M |
| Rd Expense restated | Q3 2014 · Mar 31, 2013 | $71.77M |
| Net Income | Q3 2014 · Mar 31, 2014 | −$30.65M |
| Net Income | Q3 2014 · Mar 31, 2014 | −$79.85M |
| Net Income | Q3 2014 · Mar 31, 2013 | −$20.05M |
| Net Income | Q3 2014 · Mar 31, 2013 | −$14.38M |
| Operating Income | Q3 2014 · Mar 31, 2014 | −$30.26M |
| Operating Income | Q3 2014 · Mar 31, 2014 | −$79.02M |
| Operating Income | Q3 2014 · Mar 31, 2013 | −$28.47M |
| Operating Income | Q3 2014 · Mar 31, 2013 | −$13.12M |
| Gross Profit | Q3 2014 · Mar 31, 2014 | $51.24M |
| Gross Profit | Q3 2014 · Mar 31, 2014 | $154M |
| Gross Profit restated | Q3 2014 · Mar 31, 2013 | $48.13M |
| Gross Profit restated | Q3 2014 · Mar 31, 2013 | $192.6M |
| Cost Of Revenue | Q3 2014 · Mar 31, 2014 | $49.29M |
| Cost Of Revenue | Q3 2014 · Mar 31, 2014 | $127.32M |
| Cost Of Revenue restated | Q3 2014 · Mar 31, 2013 | $39.52M |
| Cost Of Revenue restated | Q3 2014 · Mar 31, 2013 | $133.73M |
| Revenue | Q3 2014 · Mar 31, 2014 | $100.53M |
| Revenue | Q3 2014 · Mar 31, 2014 | $281.32M |
| Revenue | Q3 2014 · Mar 31, 2013 | $87.65M |
| Revenue | Q3 2014 · Mar 31, 2013 | $326.33M |